Evaluation of Treatment With Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile Men With Idiopathic Oligoasthenoteratospermia
NCT ID: NCT06342856
Last Updated: 2024-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
120 participants
INTERVENTIONAL
2023-06-15
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Acetyl- L- Carnitine& Folic Acid Versus Coenzyme Q10& Folic Acid on Semen& Hormonal Parameters& Semen Oxidative Status in Patients of Primary Infertility. A Double Blind Randomized Clinical Trial
NCT05616000
Impact of Co Enzyme Q10 as Adjuvant Therapy to Letrozole on Spermiogram
NCT05847257
Effect of Two Doses of Coenzyme Q10 on Seminal Fluid and Semen Antioxidant Status
NCT03850561
Effect of Pentoxifylline + CoQ10 vs CoQ10 Alone on Sperm Motility in Subfertile Men With Asthenozoospermia
NCT07252518
Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility
NCT03104998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
will receive a daily dose of 200 mg of CoQ10 for 3 months
co enzyme Q10 , L- Carnitine
Patient fulfilling inclusion criteria after obtaining consent will be randomized into four equal groups randomization will be computer based
Group 2
will receive L-carnitine 1 tablet per day orally for 3 months
co enzyme Q10 , L- Carnitine
Patient fulfilling inclusion criteria after obtaining consent will be randomized into four equal groups randomization will be computer based
Group 3
will receive combination of a daily dose of 200 mg of CoQ10 and 1 tablet of L-carnitine for 3 months
co enzyme Q10 , L- Carnitine
Patient fulfilling inclusion criteria after obtaining consent will be randomized into four equal groups randomization will be computer based
Group 4
will receive a placebo for 3 months
co enzyme Q10 , L- Carnitine
Patient fulfilling inclusion criteria after obtaining consent will be randomized into four equal groups randomization will be computer based
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
co enzyme Q10 , L- Carnitine
Patient fulfilling inclusion criteria after obtaining consent will be randomized into four equal groups randomization will be computer based
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with ejaculatory dysfunction
* Azoospermia
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Salvio G, Cutini M, Ciarloni A, Giovannini L, Perrone M, Balercia G. Coenzyme Q10 and Male Infertility: A Systematic Review. Antioxidants (Basel). 2021 May 30;10(6):874. doi: 10.3390/antiox10060874.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
idiopathic infertility
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.